Company: SHG
Filing Date: 2025-03-18
Form Type: 6-K
Source: 0000950170-25-040736
Chunk: 4

Company: SHINHAN FINANCIAL GROUP CO LTD
Filing Date: 2025-03-18
Form: 6-K
Chunk 4
---
 common stock in relation to a comprehensive stock exchange between SFG and Orange Life Insurance on January 28, 2020. On September 29, 2020, SFG had a paid-in capital increase and issued 39,130,000 common shares (third-party allocation). On December 30, 2020, SFG issued 72,719 shares of common stock in relation to a small-scale stock exchange between SFG and Neoplux.2) SFG acquired 1 share of treasury stocks through the acquisition of fractional shares as a result of a stock exchange between SFG and Orange Life Insurance on January 28, 2020 and between SFG and Neoplux on December 30, 2020 and 4,585,560 shares through the acquisition of treasury shares as a result of trust contract on October 25, 2024.3) SFG canceled treasury shares of 5,035,658 on June 01, 2020, 3,665,423 on 25 April, 2022, 4,149,252 on 23 November, 2022, 3,676,470 on 28 March, 2023, 4,243,281 on 16 June 2023, 2,842,929 on 31, August 2023, and 2,744,718 on 27 December 2023, 3,366,257 on 22 March 2024, and 5,974,889 on 28 October 2024 after completion of share repurchase program. Capital does not change due to the cancellation of acquired stocks within the range of dividend payable income.4) 17,482,000 shares of Convertible Preferred Shares had automatically converted to common shares on 1 May 2023 upon the completion of conversion claim period. |     |                  |

Dividends

The Company established its mid-term financial targets through the Board of Directors’ resolution on August 11, 2022, under the agenda of “Group Mid-term Strategic Establishment.” These targets included a ROE of 10.5%, ROTCE of 12.0%, and a CET1 ratio of 12.0%.

Subsequently, on February 8, 2024, through the disclosure of cash dividends and dividends in kind, the Company temporarily raised the CET1 ratio target to 13.0%, considering regulatory changes. The Company also communicated its intent to reassess the financial targets after further reviewing regulatory